Neuroeconomics to study decision-making in anxious individuals

A review in Biological Psychiatry

2012-07-24

(Press-News.org) Philadelphia, PA, July 23, 2012 – Anxiety disorders affect approximately 40 million American adults each year, and although they are treatable, they often cause significant distress.

The excessive fear and dread that accompanies anxiety disorders clearly influences the everyday decision-making processes of anxious individuals. Despite its importance, "there is surprisingly little research on how anxiety disorders influence decisions," commented neuroscientist Dr. Elizabeth Phelps, who co-authored this new review with Dr. Catherine Hartley, both of New York University.

Their review highlights that science is "starting to gain some traction by combining emerging decision science with the study of anxiety. The overlap in the neural systems underlying anxiety and decision-making provides some insight into how fear and anxiety alters choices," explained Dr. Phelps.

Dr. Hartley added, "Historically, research has focused on the influence of anxiety on how we attend to and interpret events. These same processes should shape how anxious individuals make decisions."

Their review explores the role of anxiety in decision-making using a neuroeconomic approach. Neuroeconomics is an interdisciplinary field that combines tools from the fields of economics, neuroscience, and psychology to study the brain's decision-making processes.

The authors discuss the overlap between the neural systems mediating fear and anxiety and those implicated in studies of economic decision-making. Neuroeconomics research has revealed that circuits involving the amygdala, insular cortex, and prefrontal cortex are involved in tasks with uncertainty or loss. The amygdala is a key brain region that helps regulate fear and anxiety, while the prefrontal cortex is critically involved in the control of fear.

The authors also review a set of decision-making biases exhibited by anxious individuals and propose that the neural circuitry supporting fear learning and regulation may mediate anxiety's influence upon their choices.

"Hartley and Phelps provide an elegant example of how reward-related decision making may be affected by other neural circuitries, in this case the emotional processing system," commented neuroeconomics experts Drs. Carla Sharp and P. Read Montague. "This is without a doubt part of the future of the application of neuroeconomics to psychiatric disorder, as no example of psychiatric disorder can be reduced simply to reward-related decision making."

###The article is "Anxiety and Decision-Making" by Catherine A. Hartley and Elizabeth A. Phelps (doi: 10.1016/j.biopsych.2011.12.027). The article appears in Biological Psychiatry, Volume 72, Issue 2 (July 15, 2012), published by Elsevier.

Notes for editors Full text of the article is available to credentialed journalists upon request; contact Rhiannon Bugno at +1 214 648 0880 or Biol.Psych@utsouthwestern.edu. Journalists wishing to interview the authors may contact Elizabeth Phelps at +1 212 998 8337or liz.phelps@nyu.edu.

The authors' affiliations, and disclosures of financial and conflicts of interests are available in the article.

About Biological Psychiatry Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic and clinical contributions from all disciplines and research areas relevant to the pathophysiology and treatment of major psychiatric disorders.

The journal publishes novel results of original research which represent an important new lead or significant impact on the field, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Reviews and commentaries that focus on topics of current research and interest are also encouraged.

Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 5th out of 129 Psychiatry titles and 16th out of 243 Neurosciences titles in the Journal Citations Reports® published by Thomson Reuters. The 2011 Impact Factor score for Biological Psychiatry is 8.283.

About Elsevier Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, MD Consult and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Rhiannon Bugno
Editorial Office, Biological Psychiatry
+1 214 648 0880
biol.psych@utsouthwestern.edu

ELSE PRESS RELEASES FROM THIS DATE:

Largest review of management and treatment of Barrett's dysplasia and adenocarcinoma

2012-07-24

The world's largest review of all the evidence on the best way of managing and treating common pre-cancerous and cancerous conditions of the oesophagus (gullet) has found that good endoscopy equipment, more endoscopic surgery, and more tissue sampling are required to improve care for patients. The multi-national team of researchers led by Professor Janusz Jankowski of the Blizard Institute of Cell and Molecular Science at Queen Mary, University of London (UK), reviewed nearly 12,000 papers on the care and treatment of Barrett's Dysplasia and early-stage oesophageal adenocarcinoma. ...

Croscat Volcano may have been the last volcanic eruption in Spain 13,000 years ago

2012-07-24

The volcanic region of La Garrotxa, with some forty volcanic cones and some twenty lava flows, is considered to be the best conserved region in the Iberian Peninsula. It is also the youngest volcanic area. Although the approximate age of some of these volcanic constructions is known, one of the main problems when studying volcanoes is to pinpoint the chronology of each of their eruptions. Several geochronological studies have been conducted, but existing data is scarce and imprecise. With regard to the chronology of the Croscat Volcano, considered one of the most recent ...

America Invents Act is a game changer

2012-07-24

TAMPA, Fla. (Jul. 23, 2012) – In an article published in the current issue of Technology and Innovation- Proceedings of the National Academy of Inventors® (https://www.cognizantcommunication.com/journal-titles/technology-a-innovation?page=shop.product_details&flypage=flypage.tpl&product_id=56&category_id=16), Janet Gongola, Patent Reform Coordinator for the U.S. Patent and Trademark Office (USPTO), describes the process of implementing the America Invents Act (2011, H,R. 1249), the first patent law reform in 60 years. "The America Invents Act is the foundation for a 21st ...

Traveling through the volcanic conduit

2012-07-24

How much ash will be injected into the atmosphere during Earth's next volcanic eruption? Recent eruptions have demonstrated our continued vulnerability to ash dispersal, which can disrupt the aviation industry and cause billions of dollars in economic loss. Scientists widely believe that volcanic particle size is determined by the initial fragmentation process, when bubbly magma deep in the volcano changes into gas-particle flows. But new Georgia Tech research indicates a more dynamic process where the amount and size of volcanic ash actually depend on what happens afterward, ...

Powerful class of antioxidants may be potent Parkinson's treatment

2012-07-24

AUGUSTA, Ga. – A new and powerful class of antioxidants could one day be a potent treatment for Parkinson's disease, researchers report. A class of antioxidants called synthetic triterpenoids blocked development of Parkinson's in an animal model that develops the disease in a handful of days, said Dr. Bobby Thomas, neuroscientist at the Medical College of Georgia at Georgia Health Sciences University and corresponding author of the study in the journal Antioxidants & Redox Signaling. Thomas and his colleagues were able to block the death of dopamine-producing brain ...

New model of disease contagion ranks US airports in terms of their spreading influence

2012-07-24

CAMBRIDGE, Mass. -- Public health crises of the past decade — such as the 2003 SARS outbreak, which spread to 37 countries and caused about 1,000 deaths, and the 2009 H1N1 flu pandemic that killed about 300,000 people worldwide — have heightened awareness that new viruses or bacteria could spread quickly across the globe, aided by air travel. While epidemiologists and scientists who study complex network systems — such as contagion patterns and information spread in social networks — are working to create mathematical models that describe the worldwide spread of disease, ...

Researchers develop ginseng-fortified milk to improve cognitive function

2012-07-24

Amsterdam, The Netherlands, July 23, 2012 – American ginseng is reported to have neurocognitive effects, and research has shown benefits in aging, central nervous system disorders, and neurodegenerative diseases. The challenges of incorporating ginseng into food are twofold: it has a bitter taste, and food processing can eliminate its healthful benefits. Reporting in the August issue of the Journal of Dairy Science®, a group of scientists has formulated low-lactose functional milk that maintained beneficial levels of American ginseng after processing. An exploratory ...

Trial signals major milestone in hunt for new TB drugs

2012-07-24

WASHINGTON, DC/LONDON (July 23, 2012) – A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the Lancet. These results add to a growing body of evidence that the new regimen could reduce treatment by more than a year for some patients. The findings from researchers and the non-profit TB Alliance raise hope ...

Neural precursor cells induce cell death in certain brain tumors

2012-07-24

Neural precursor cells (NPC) in the young brain suppress certain brain tumors such as high-grade gliomas, especially glioblastoma (GBM), which are among the most common and most aggressive tumors. Now researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité – Universitätsmedizin Berlin have deciphered the underlying mechanism of action with which neural precursor cells protect the young brain against these tumors. They found that the NPC release substances that activate TRPV1 ion channels in the tumor cells and subsequently induce the ...

Study shows why some types of multitasking are more dangerous than others

2012-07-24

COLUMBUS, Ohio - In a new study that has implications for distracted drivers, researchers found that people are better at juggling some types of multitasking than they are at others. Trying to do two visual tasks at once hurt performance in both tasks significantly more than combining a visual and an audio task, the research found. Alarmingly, though, people who tried to do two visual tasks at the same time rated their performance as better than did those who combined a visual and an audio task - even though their actual performance was worse. "Many people have this ...

Northwestern Medicine, West Health, Meadows Mental Health Policy Institute collaboration to provide easier access to mental health care

Is therapeutic hypothermia an effective treatment for hypoxic-ischemic encephalopathy, a type of neurological dysfunction in newborns?

New AEM study highlights feasibility of cranial accelerometry device for prehospital detection of large-vessel occlusion stroke

[Press-News.org] Neuroeconomics to study decision-making in anxious individuals
A review in Biological Psychiatry

Neuroeconomics to study decision-making in anxious individuals

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: